Hendrik Bonnemeier
Papers
1
Total Citations
12
H-Index
1
About
Hendrik Bonnemeier is a leading cardiologist and researcher whose work sits at the critical intersection of cardiac electrophysiology and radiation oncology. His primary research focuses on the innovative use of stereotactic body radiotherapy (SBRT) for the non-invasive treatment of ventricular tachycardia (VT), a life-threatening heart rhythm disorder. Bonnemeier’s major contribution is his central role in the RAdiosurgery for VENtricular TAchycardia (RAVENTA) trial, a landmark multicenter initiative. His highly cited 2022 paper, "Treatment Planning for Cardiac Radioablation," established the first multi-platform benchmarking standards for this novel procedure, ensuring reproducibility and safety across different clinical centers. This foundational work has directly shaped the field of cardiac radioablation, providing the technical framework for a paradigm shift away from invasive catheter ablation. With over 12 citations in a rapidly evolving field, his research is already guiding clinical practice and future trials. Bonnemeier’s achievements include pioneering the integration of advanced imaging and radiation planning for precise cardiac targeting, offering new hope for patients with refractory VT.
Research Focus
Key Achievements
Top Papers
- 1